Wade G W & Inc Vincerx Pharma, Inc. Transaction History
Wade G W & Inc
- $3.08 Billion
- Q4 2023
A detailed history of Wade G W & Inc transactions in Vincerx Pharma, Inc. stock. As of the latest transaction made, Wade G W & Inc holds 10,900 shares of VINC stock, worth $8,175. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,900
Previous 10,900
-0.0%
Holding current value
$8,175
Previous $11,000
18.18%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VINC
# of Institutions
39Shares Held
8.46MCall Options Held
0Put Options Held
0-
Sage Rhino Capital LLC1.7MShares$1.28 Million2.1% of portfolio
-
Octagon Capital Advisors LP New York, NY1MShares$750,0000.79% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct955KShares$716,1200.01% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD892KShares$668,7890.12% of portfolio
-
Bank Of America Corp Charlotte, NC701KShares$526,0670.0% of portfolio
About Vincerx Pharma, Inc.
- Ticker VINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,189,800
- Market Cap $15.9M
- Description
- Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...